Preliminary report of a phase 1/2A open-label study of EKB-569 in combination with 5-fluorouracil, leucovorin, and irinotecan in patients with advanced colorectal cancer

Research output: Contribution to journal › Meeting abstract › Contributed › peer-review

Contributors

  • R Salazar - (Author)
  • CH Koehne - (Author)
  • H Cortes-Funes - (Author)
  • J Tabernero - (Author)
  • G Folprecht - , Department of internal Medicine I (Author)
  • L Paz-Ares - (Author)
  • J Baselga - (Author)
  • SE Quinn - (Author)
  • C Zacharchuk - (Author)

Details

Original languageEnglish
Pages (from-to)6099S-6100S
Number of pages2
JournalClinical cancer research
Volume9
Issue number16
Publication statusPublished - 1 Dec 2003
Peer-reviewedYes

Conference

TitleAACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Duration17 - 21 November 2003
CityBOSTON

External IDs

ORCID /0000-0002-9321-9911/work/142252040

Keywords

Sustainable Development Goals